Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia

Table 2

Response stratified by genetic risk group.

Risk group	CR + CRi; N (%)
Favorable (N = 5)	4 (80)
Intermediate I (N = 10)	7 (70)
Intermediate II (N = 6)	3 (50)
Poor (N = 5)	2 (40)

CR: complete response; CRi: complete response with incomplete count recovery.